|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02480 LUZHU BIOTECH-B
Nominal 
22.400 +0.450 (+2.050%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 |
| Property, plant, equip. & others | 383,905 | 67.186% | 229,627 | 76,029 |
| Land & other Lease Assets | 104,591 | -2.922% | 107,739 | 66,180 |
| Intangible Assets | 4,127 | 20.076% | 3,437 | 0 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 |
| Other Non-current Assets | 53,099 | -58.634% | 128,363 | 9,393 |
| 545,722 | 16.317% | 469,166 | 151,602 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | 0 | -- | 0 | 0 | |
| Trade Receivables | 0 | -- | 0 | 0 | |
| Cash & Bank Balances | 264,982 | 284.166% | 68,976 | 32,030 | |
| Other Current Assets | 355,990 | -33.088% | 532,028 | 542,263 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | |
| 620,972 | 3.322% | 601,004 | 574,293 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | 0 | -- | 0 | 0 | ||
| S-T Debt & Leases | 7,129 | -- | 0 | 0 | ||
| Other Current Liabilities | 89,183 | -5.239% | 94,114 | 23,422 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | ||
| 96,312 | 2.335% | 94,114 | 23,422 | |||
| Net Current Assets | 524,660 | 3.506% | 506,890 | 550,871 | ||
| Total Assets Less Current Liabilities | 1,070,382 | 9.664% | 976,056 | 702,473 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | 12,087 | 7.737% | 11,219 | 10,580 | |||
| Other Non-current Liabilities | 37,667 | 37.616% | 27,371 | 1,276,418 | |||
| 49,754 | 28.930% | 38,590 | 1,286,998 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | 202,450 | 5.408% | 192,064 | 90,888 | ||||
| Reserves | 818,178 | 9.763% | 745,402 | (675,413) | ||||
| Others | 0 | -- | 0 | 0 | ||||
| Shareholders' Funds | 1,020,628 | 8.871% | 937,466 | (584,525) | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| 1,020,628 | 8.871% | 937,466 | (584,525) | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Final to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 13,498 | 25,107 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 08/08/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -249,350,000 |
| %Change | -65.615% |
| EPS / (LPS) | RMB -1.250 |
| NBV Per Share (¥) | RMB 5.041 |